RECOMBINANT HUMAN ALBUMIN-HUMAN GRANULOCYTE COLONY STIMULATING FACTOR FOR THE PREVENTION OF NEUTROPENIA IN PEDIATRIC PATIENTS

摘要

Disclosed are methods and compositions for treating, preventing and ameliorating conditions and diseases characterized by a lowered white blood cell count, including neutropenia, in human patients that are less than 18 years old. The methods and compositions described herein include a fusion polypeptide comprising human serum albumin protein ("HSA") and human granulocyte-colony stimulating factor ("G-CSF").